Concepedia

Alejandro Díaz‐Holguín

AD

4

Publications

81

Citations

4

H-Index

2022

Active since

Affiliations

Uppsala University(Current)

Universidade de Santiago de Compostela

Center for Research in Molecular Medicine and Chronic Diseases

Science for Life Laboratory

Alejandro Díaz‐Holguín is an author at Uppsala University specializing in drug discovery, medicinal chemistry, and molecular docking.

ORCID

Top concepts

Publications per year

2022–2024

4

Publications

4

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo et al. · Science Advances · 2024 · 42 citations · Full text

, , +19

Exploring the Effect of Halogenation in a Series of Potent and Selective A<sub>2B</sub> Adenosine Receptor Antagonists

Rubén Prieto‐Díaz, Manuel A. González‐Gómez, Hugo Fojo-Carballo et al. · Journal of Medicinal Chemistry · 2022 · 16 citations · Full text

When Two Become One: Conformational Changes in FXR/RXR Heterodimers Bound to Steroidal Antagonists

Alejandro Díaz‐Holguín, Azam Rashidian, Dirk Pijnenburg et al. · ChemMedChem · 2022 · 12 citations · Full text

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A<sub>1</sub> Antagonists

Cristina Val, Carlos Rodríguez-García, Rubén Prieto‐Díaz et al. · Journal of Medicinal Chemistry · 2022 · 11 citations · Full text

Rows per page

1–4 of 4